0.1726
-0.0499
(-22.43%)
At close: January 30 at 8:03:32 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
--
--
3,892.0000
8,723.0000
--
Operating Expense
57,451.0000
111,475.0000
147,670.0000
137,897.0000
93,257.0000
Operating Income
-57,451.0000
-111,475.0000
-147,670.0000
-137,897.0000
-93,257.0000
Net Non Operating Interest Income Expense
-5,558.0000
1,321.0000
587.0000
-67.0000
14.0000
Pretax Income
-62,462.0000
-109,607.0000
-133,155.0000
-129,523.0000
-99,747.0000
Tax Provision
-165.0000
-319.0000
-1,933.0000
-3,620.0000
-1,050.0000
Net Income Common Stockholders
-62,296.0000
-109,288.0000
-131,223.0000
-125,903.0000
-98,697.0000
Diluted NI Available to Com Stockholders
-62,296.0000
-109,288.0000
-131,223.0000
-125,903.0000
-98,697.0000
Basic EPS
-0.61
-2.24
-2.61
-2.64
-2.60
Diluted EPS
-0.61
-2.24
-2.61
-2.64
-2.60
Basic Average Shares
53,212.3590
48,742.7130
50,302.0350
47,643.1490
37,975.1210
Diluted Average Shares
53,212.3590
48,742.7130
50,302.0350
47,643.1490
37,975.1210
Total Operating Income as Reported
-56,890.0000
-110,914.0000
-147,007.0000
-137,948.0000
-93,428.0000
Total Expenses
57,451.0000
111,475.0000
147,670.0000
137,897.0000
93,257.0000
Net Income from Continuing & Discontinued Operation
-62,296.0000
-109,288.0000
-131,223.0000
-125,903.0000
-98,697.0000
Normalized Income
-62,296.0000
-109,288.0000
-131,223.0000
-125,903.0000
-99,376.7682
Interest Income
-183.0000
1,321.0000
635.0000
10.0000
27.0000
Interest Expense
5,375.0000
--
48.0000
77.0000
13.0000
Net Interest Income
-5,558.0000
1,321.0000
587.0000
-67.0000
14.0000
EBIT
-57,087.0000
-109,607.0000
-133,107.0000
-129,446.0000
-99,734.0000
EBITDA
-57,087.0000
-109,607.0000
-133,107.0000
-129,446.0000
-99,734.0000
Reconciled Cost of Revenue
--
--
3,892.0000
8,723.0000
--
Net Income from Continuing Operation Net Minority Interest
-62,296.0000
-109,288.0000
-131,223.0000
-125,903.0000
-98,697.0000
Total Unusual Items Excluding Goodwill
--
--
--
--
687.0000
Total Unusual Items
--
--
--
--
687.0000
Normalized EBITDA
-57,087.0000
-109,607.0000
-133,107.0000
-129,446.0000
-100,421.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
--
--
--
--
7.2318
12/31/2020 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PMRA.BE Pharma Mar SA
85.10
-1.10%
BITRF Biotron Limited
0.0497
0.00%
INNMF Amplia Therapeutics Limited
0.0450
0.00%
22Z.BE Zealand Pharma A/S
98.45
+0.87%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
CLABF Core One Labs Inc.
0.0366
-18.67%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
WSNAF Wesana Health Holdings Inc.
0.0685
0.00%
BETRF BetterLife Pharma Inc.
0.1140
0.00%